Trial · NCT02589925
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | safety as determined by spontaneously reported adverse events | 48 weeks | Safety of combined bilateral subthalamic nucleus (STN) and basal nucleus of Meynert (NBM) stimulation as determined by spontaneously reported adverse events |
| Other | Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog) | 48 weeks | |
| Other | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADAS-CGIC) | 48 weeks | |
| Other | Alzheimer's Disease Co-operative Study - Activities of Daily Living Inventory (ADCS-ADL) | 48 weeks | |
| Other | Unified Parkinson's Disease Rating Scale section II (UPDRS II) | 48 weeks | Unified Parkinson's Disease Rating Scale section II |
| Other | Beck Depression Inventory (BDI) | 48 weeks | |
| Other | Neuropsychiatric Inventory (NPI) | 48 weeks | |
| Other | Verbal Fluency | 48 weeks | Combined verbal fluency score from D-KEFS battery, Wisconsin Card Sorting Test (modified version), Trail Making Task Part A + B, Stroop Test (Victoria Version), Symbol Digit Modalities Test |
| Other | Brief Test of Attention | 48 weeks | auditory perception task that measures divided attention in the verbal-linguistic system |
| Other | Starkstein Apathy Scale | 48 weeks | |
| Other | Unified Parkinson's Disease Rating Scale section III (UPDRS III) | 48 weeks | |
| Other | Clinical Dyskinesia Rating Scale (CDRS) | 48 weeks | |
| Other | EQ-5d | 48 weeks | EQ-5D questionnaire of the EuroQol-group |
| Other | Parkinson's Disease Questionnaire for quality of life (PDQ39) | 48 weeks | |
| Other | Caregiver burden assessment/SF36 | 48 weeks | |
| Other | Direct and indirect costs | 48 weeks | cost of treatment, loss of caregiver productivity, loss of patient productivity, etc. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02589925/registered